1,4-Dioxane hydrochloride → N-methyl-4-(5-methyl-1-oxo-1,2-dihydro-isoquinolin-3-yl)-N-piperidin-4-ylmethyl-benzamide
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][N:15]([CH3:36])[C:16](=[O:35])[C:17]2[CH:22]=[CH:21][C:20]([C:23]3[NH:24][C:25](=[O:34])[C:26]4[C:31]([CH:32]=3)=[C:30]([CH3:33])[CH:29]=[CH:28][CH:27]=4)=[CH:19][CH:18]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.Cl.O1CCOCC1>C(Cl)Cl>[CH3:36][N:15]([CH2:14][CH:11]1[CH2:10][CH2:9][NH:8][CH2:13][CH2:12]1)[C:16](=[O:35])[C:17]1[CH:18]=[CH:19][C:20]([C:23]2[NH:24][C:25](=[O:34])[C:26]3[C:31]([CH:32]=2)=[C:30]([CH3:33])[CH:29]=[CH:28][CH:27]=3)=[CH:21][CH:22]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To 4-({methyl-[4-(5-methyl-1-oxo-1,2-dihydro-isoquinolin-3-yl)-benzoyl]-amino}-methyl)-piperidine-1-carboxylic acid tert-butyl ester (170 mg, 0.35 mmol) in CH2Cl2 (5 mL) was added 4M HCl/dioxane (2 mL) and the reaction mixture stirred at RT for 4 h. The solvent was removed in vacuo and the crude product purified by reverse phase preparative HPLC-MS to obtain N-methyl-4-(5-methyl-1-oxo-1,2-dihydro-isoquinolin-3-yl)-N-piperidin-4-ylmethyl-benzamide as a pale orange solid (44 mg, 33%).
Workup
- customThe solvent was removed in vacuo
- customthe crude product purified by reverse phase preparative HPLC-MS
Sources & evidence
- ORD record
- ord-2be7e25c9db54c0e9845bda66452953b
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09193689B2
Reaction notes
Loading…